Telix Pharmaceuticals Lim...

NASDAQ: TLX · Real-Time Price · USD
16.86
0.06 (0.38%)
At close: Jun 18, 2025, 3:59 PM
16.96
0.59%
After-hours: Jun 18, 2025, 05:52 PM EDT
0.38%
Bid 16.01
Market Cap 5.7B
Revenue (ttm) 24.45M
Net Income (ttm) -1.98M
EPS (ttm) 0.09
PE Ratio (ttm) 187.33
Forward PE n/a
Analyst Strong Buy
Ask 17.54
Volume 7,981
Avg. Volume (20D) 23,730
Open 16.87
Previous Close 16.80
Day's Range 16.55 - 17.10
52-Week Range 13.61 - 30.36
Beta 2.41

About TLX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TLX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 months ago
+12%
Telix Pharmaceuticals shares are trading higher af... Unlock content with Pro Subscription
4 months ago
+1.07%
Telix Pharmaceuticals shares are trading higher after the company announced it will buy the therapeutic pipeline, technology platform, and research facility from ImaginAb.